References
1. Atzrodt CL, Maknojia I, McCarthy RDP, Oldfield TM, Po J, Ta KTL, et al. A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2. Febs j. 2020;287(17):3633-50.
2. Vitiello A, Ferrara F, Troiano V, La Porta R. COVID-19 vaccines and decreased transmission of SARS-CoV-2. Inflammopharmacology. 2021;29(5):1357-60.
3. Mohamed K, Rzymski P, Islam MS, Makuku R, Mushtaq A, Khan A, et al. COVID-19 vaccinations: The unknowns, challenges, and hopes. J Med Virol. 2022;94(4):1336-49.
4. Guo W, Deguise J, Tian Y, Huang PC-E, Goru R, Yang Q, et al. Profiling COVID-19 Vaccine Adverse Events by Statistical and Ontological Analysis of VAERS Case Reports. Frontiers in Pharmacology. 2022;13.
5. Chi W-Y, Li Y-D, Huang H-C, Chan TEH, Chow S-Y, Su J-H, et al. COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection. Journal of Biomedical Science. 2022;29(1):82.
6. Ng XL, Betzler BK, Ng S, Chee SP, Rajamani L, Singhal A, et al. The Eye of the Storm: COVID-19 Vaccination and the Eye. Ophthalmol Ther. 2022;11(1):81-100.
7. Wang MTM, Niederer RL, McGhee CNJ, Danesh-Meyer HV. COVID-19 Vaccination and The Eye. Am J Ophthalmol. 2022;240:79-98.
8. Méndez Mangana C, Barraquer Kargacin A, Barraquer RI. Episcleritis as an ocular manifestation in a patient with COVID-19. Acta Ophthalmol. 2020;98(8):e1056-e7.
9. Otaif W, Al Somali AI, Al Habash A. Episcleritis as a possible presenting sign of the novel coronavirus disease: A case report. Am J Ophthalmol Case Rep. 2020;20:100917.
10. Pichi F, Aljneibi S, Neri P, Hay S, Dackiw C, Ghazi NG. Association of Ocular Adverse Events With Inactivated COVID-19 Vaccination in Patients in Abu Dhabi. JAMA Ophthalmol. 2021;139(10):1131-5.
11. Moorthy RS, Moorthy MS, Cunningham ET, Jr. Drug-induced uveitis. Curr Opin Ophthalmol. 2018;29(6):588-603.
12. Cunningham ET, Jr., Moorthy RS, Fraunfelder FW, Zierhut M. Vaccine-Associated Uveitis. Ocul Immunol Inflamm. 2019;27(4):517-20.
13. Teijaro JR, Farber DL. COVID-19 vaccines: modes of immune activation and future challenges. Nat Rev Immunol. 2021;21(4):195-7.
14. Rodero MP, Crow YJ. Type I interferon-mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview. J Exp Med. 2016;213(12):2527-38.
15. Bolles M, Deming D, Long K, Agnihothram S, Whitmore A, Ferris M, et al. A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge. J Virol. 2011;85(23):12201-15.
16. See RH, Zakhartchouk AN, Petric M, Lawrence DJ, Mok CPY, Hogan RJ, et al. Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus. J Gen Virol. 2006;87(Pt 3):641-50.
17. Manzo G. COVID-19 as an immune complex hypersensitivity in antigen excess conditions: theoretical pathogenetic process and suggestions for potential therapeutic interventions. Frontiers in Immunology. 2020;11:566000.
18. Ng XL, Betzler BK, Testi I, Ho SL, Tien M, Ngo WK, et al. Ocular Adverse Events After COVID-19 Vaccination. Ocul Immunol Inflamm. 2021;29(6):1216-24.
19. Papasavvas I, Herbort CP, Jr. Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination. J Ophthalmic Inflamm Infect. 2021;11(1):21.
20. Mudie LI, Zick JD, Dacey MS, Palestine AG. Panuveitis following Vaccination for COVID-19. Ocul Immunol Inflamm. 2021;29(4):741-2.
21. Pan L, Zhang Y, Cui Y, Wu X. Bilateral uveitis after inoculation with COVID-19 vaccine: A case report. Int J Infect Dis. 2021;113:116-8.
22. Fowler N, Mendez Martinez NR, Pallares BV, Maldonado RS. Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine. Am J Ophthalmol Case Rep. 2021;23:101136.
23. Reshef ER, Freitag SK, Lee NG. Orbital Inflammation Following COVID-19 Vaccination. Ophthalmic Plast Reconstr Surg. 2022;38(3):e67-e70.
24. Turner JS, O’Halloran JA, Kalaidina E, Kim W, Schmitz AJ, Zhou JQ, et al. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature. 2021;596(7870):109-13.
25. Rahmani A, Dini G, Montecucco A, Orsi A, Sticchi L, Domnich A, et al. Adverse Reactions after the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine among Medical School Residents in a Regional Reference University Hospital in Italy. Vaccines (Basel). 2022;10(11).
26. Leibowitz JA, Woods AT, Kesselman MM, Mayi BS. Uveitis as a Predictor of Predisposition to Autoimmunity. Cureus. 2020;12(3):e7451.